Bioventus (BVS) Minority Interest (2021 - 2026)

Bioventus' Minority Interest history runs 6 years deep, the most recent figure standing at $45.4 million for Q1 2026.

• Quarterly Minority Interest rose 21.51% year-over-year to $45.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.4 million (up 21.51% YoY) and the FY2025 annual result came in at $44.3 million, up 17.73% from the prior year.
• Minority Interest was $45.4 million for Q1 2026 at Bioventus, up from $44.3 million in the prior quarter.
• Across five years, Minority Interest topped out at $87.0 million in Q4 2022 and bottomed at $35.7 million in Q4 2022.
• A 5-year average of $49.0 million and a median of $45.4 million in 2026 frame the typical range for Minority Interest.
• Annual changes were most pronounced in 2022 — Minority Interest plunged 54.16% — and 2023, when it surged 36.86%.
• Bioventus' Minority Interest stood at $87.0 million in 2022, then sank by 45.36% to $47.5 million in 2023, then declined by 20.75% to $37.7 million in 2024, then gained by 17.73% to $44.3 million in 2025, then gained by 2.3% to $45.4 million in 2026.
• Business Quant data shows BVS's Minority Interest at $45.4 million in Q1 2026, $44.3 million in Q4 2025, and $41.2 million in Q3 2025.